Cleared Traditional

Elecsys CA 15-3 II

K171605 · Roche Diagnostics · Immunology
Feb 2018
Decision
264d
Days
Class 2
Risk

About This 510(k) Submission

K171605 is an FDA 510(k) clearance for the Elecsys CA 15-3 II, a System, Test, Immunological, Antigen, Tumor (Class II — Special Controls, product code MOI), submitted by Roche Diagnostics (Indianapolos, US). The FDA issued a Cleared decision on February 20, 2018, 264 days after receiving the submission on June 1, 2017. This device falls under the Immunology review panel. Regulated under 21 CFR 866.6010.

Submission Details

510(k) Number K171605 FDA.gov
FDA Decision Cleared SESE
Date Received June 01, 2017
Decision Date February 20, 2018
Days to Decision 264 days
Submission Type Traditional
Review Panel Immunology (IM)
Summary Summary PDF

Device Classification

Product Code MOI — System, Test, Immunological, Antigen, Tumor
Device Class Class II — Special Controls
CFR Regulation 21 CFR 866.6010

Similar Devices — MOI System, Test, Immunological, Antigen, Tumor

All 27
Access BR Monitor
K240403 · Beckman Coulter, Inc. · May 2024
IMMULITE? 2000 BR-MA
K233946 · Siemens Healthcare Diagnostics Products, Ltd. · Mar 2024
Lumipulse G CA15-3
K192524 · Fujirebio Diagnostics,Inc. · Sep 2020
ADVIA Centaur BR
K193489 · Siemens Healthcare Diagnostics, Inc. · Feb 2020
ADVIA Centaur CA 15-3 assay
K192777 · Siemens Healthcare Diagnostics, Inc. · Nov 2019
Elecsys CA 15-3 II
K181492 · Roche Diagnostics · Jun 2018